Skip to content

How Can I Get Rezdiffra? A Comprehensive Guide to Accessing the First MASH Medication

4 min read

In March 2024, Rezdiffra (resmetirom) became the first and only FDA-approved medication for adults with non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH), formerly known as NASH, with moderate to advanced liver fibrosis. The path to accessing this medication involves specific steps, including a diagnosis from a liver specialist, gaining insurance approval, and navigating a specialty pharmacy network to understand how can I get Rezdiffra.

Quick Summary

Accessing the MASH medication Rezdiffra requires a diagnosis from a liver specialist and confirmation of moderate to advanced liver fibrosis. The prescription must be filled through a limited network of specialty pharmacies, which manage insurance verification, prior authorization, and home delivery. Financial assistance is available through manufacturer-sponsored support programs.

Key Points

  • Specialist Diagnosis Required: Rezdiffra must be prescribed by a liver specialist (gastroenterologist or hepatologist) after confirming MASH and moderate to advanced fibrosis.

  • Specialty Pharmacy Distribution: The medication is only available through a limited network of specialty pharmacies and is not stocked at standard retail locations.

  • Prior Authorization is Common: Insurance coverage typically requires a prior authorization process, where the doctor provides documentation to the insurer.

  • Madrigal Patient Support is Key: The manufacturer offers a support program to help patients navigate insurance, prior authorization, and find financial assistance.

  • Financial Aid is Available: Eligible patients can access copay savings programs or patient assistance programs to reduce the high cost of the medication.

  • Lifestyle Commitment is Necessary: Rezdiffra is to be used as an adjunct to diet and exercise, which must be documented by your prescriber.

In This Article

The Initial Diagnosis and Prescription

Before you can begin to get Rezdiffra, you must be properly diagnosed by a qualified healthcare provider. Rezdiffra is specifically approved for adults with non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH), a progressive form of fatty liver disease, and moderate to advanced liver fibrosis (stages F2 and F3). The prescribing and reauthorization process often requires consultation with a liver specialist, such as a gastroenterologist or hepatologist.

Your liver specialist will confirm your diagnosis using specific tests. This may include:

  • Liver biopsy: Considered the gold standard, a biopsy performed within the last few years may be required by some insurers.
  • Non-invasive tests: These are increasingly common and may include tests like FibroScan (VCTE), Magnetic Resonance Elastography (MRE), and the Fibrosis-4 (FIB-4) index.
  • Documentation of eligibility: The prescriber must also confirm that you are not in an advanced stage of cirrhosis or experiencing liver decompensation.

Additionally, Rezdiffra must be used in conjunction with lifestyle changes, including diet and exercise. The prescriber must document this commitment as part of the approval process.

Navigating Insurance and Prior Authorization

Given its specialized nature and high cost, most insurance providers, including commercial plans and Medicare, require prior authorization (PA) before covering Rezdiffra. Prior authorization is a process where your doctor sends detailed medical information to your insurance company to prove that the medication is medically necessary based on their specific criteria.

The PA process can take days to weeks and requires close coordination between your doctor's office and your insurance provider. A dedicated case manager from the manufacturer's patient support program can often help streamline this complex process.

Accessing the Medication through Specialty Pharmacies

Unlike medications available at a standard retail pharmacy, Rezdiffra is distributed through a limited network of specialty pharmacies. These pharmacies are equipped to handle complex and high-cost medications and provide specialized support services to patients.

Once the prescription is approved, the specialty pharmacy will coordinate with you to confirm coverage and schedule delivery directly to your home. They will also manage refills and ongoing support.

Specialty Pharmacy vs. Retail Pharmacy

Feature Specialty Pharmacy for Rezdiffra Retail Pharmacy (Typically Not an Option)
Distribution Network Limited, specialized network authorized by the manufacturer Widespread retail locations
Required Prescription Must be prescribed by a liver specialist (hepatologist or gastroenterologist) Can be prescribed by various practitioners
Prior Authorization (PA) Managed by the specialty pharmacy with support from manufacturer programs Handled by retail pharmacy or doctor, but unlikely for Rezdiffra
Patient Support Offers extensive support, including financial assistance navigation, nurse navigators, and case managers Standard dispensing services, limited specialized support
Delivery Method Medication is shipped directly to the patient's home In-person pickup at a local store
Cost Management Provides assistance options like copay savings and Patient Assistance Programs May offer discount cards, but limited in scope for specialty drugs

Financial Assistance Programs

Due to the significant cost of Rezdiffra, financial assistance is often necessary. The manufacturer, Madrigal Pharmaceuticals, offers a program called Madrigal Patient Support, which is designed to help patients with insurance and affordability issues.

Through this program, eligible patients can receive help with:

  • Copay Savings Program: For commercially insured patients, this program can reduce out-of-pocket costs to as low as $0 per month.
  • Patient Assistance Program (PAP): A specific program designed to provide Rezdiffra at no cost to eligible uninsured or underinsured patients.
  • Coverage Assistance: The program can help navigate insurance plans and prior authorization requirements.

Enrolling in the Madrigal Patient Support program is a crucial step. Your doctor's office can help with enrollment, or you can register online. A case manager will contact you to discuss your options and guide you through the process.

The Step-by-Step Process to Get Rezdiffra

  1. Consult with a Liver Specialist: Schedule an appointment with a gastroenterologist or hepatologist to discuss your MASH diagnosis and treatment options. A primary care physician may provide an initial referral.
  2. Confirm Eligibility and Diagnosis: The specialist will perform or review diagnostic tests (biopsy or non-invasive imaging) to confirm MASH and the fibrosis stage. They will ensure you meet all clinical criteria.
  3. Receive a Prescription and Enroll in Support: If you are a candidate, the liver specialist will write a prescription and, often, enroll you in the Madrigal Patient Support program.
  4. Navigate Insurance and Prior Authorization: A case manager from the patient support program or specialty pharmacy will help secure prior authorization from your insurance company.
  5. Utilize Financial Assistance: The support program will help identify and enroll you in financial assistance programs, such as the copay card or PAP, if you are eligible.
  6. Receive Medication from a Specialty Pharmacy: The specialty pharmacy will ship the medication directly to you after all approvals are complete. They will also manage future refills.

Conclusion

Getting Rezdiffra is a multi-step process that hinges on a specialist diagnosis, insurance approval via prior authorization, and a specialty pharmacy. While this path may seem complicated, the support provided by the manufacturer's patient program is designed to guide you through it. Starting with a consultation with a liver specialist is the essential first step, followed by active participation in the support programs to manage access and cost.

For more information on the manufacturer's program, visit the Madrigal Patient Support website. Learn more about the Madrigal Patient Support program.

Frequently Asked Questions

Rezdiffra is the first FDA-approved medication for adults with non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH), formerly known as NASH, who also have moderate to advanced liver fibrosis (scarring).

While your primary care doctor can provide an initial referral, the prescription for Rezdiffra must come from a liver specialist, such as a gastroenterologist or hepatologist, as required by many insurance and manufacturer programs.

A diagnosis is confirmed through specific tests, which may include a liver biopsy or non-invasive methods like FibroScan or Magnetic Resonance Elastography (MRE), to assess the severity of fibrosis.

Rezdiffra is a complex, high-cost medication that requires careful management and patient support. Specialty pharmacies are equipped to handle these unique requirements, including managing insurance approval and providing specialized patient services.

Prior authorization is an approval process required by most insurance plans for high-cost, specialized medications. Your doctor must provide documentation to prove medical necessity. It is very likely you will need prior authorization for Rezdiffra.

The manufacturer, Madrigal Pharmaceuticals, offers the Madrigal Patient Support program, which can provide financial assistance. Options include a copay savings program for those with commercial insurance and a patient assistance program for uninsured or underinsured patients.

You can enroll in the Madrigal Patient Support program through your liver specialist's office or by registering online. A case manager will contact you to review available resources and guide you through the process.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.